---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-000611"
form_type: "8-K"
ticker: "SNOA"
cik: "0001367083"
company_name: "Sonoma Pharmaceuticals, Inc."
filed_at: "2025-01-30T23:59:59+00:00"
generated_at: "2026-05-27T05:13:01.646252+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Sonoma inks exclusive US distribution deal with WellSpring for Microcyn products

## Summary
- Exclusive US distribution agreement with WellSpring Pharmaceutical, effective Jan 29, 2025.
- Initial term of 2 years with three automatic one-year renewal periods.
- WellSpring to distribute Microcyn-based products through defined channels; Sonoma retains all IP.
- WellSpring must use commercially reasonable efforts and cannot sell competing hypochlorous acid products in those channels.
- Pricing, minimum quantities, and forecasts are set in confidential attachments.

## SEC filing metadata
- accession: 0001683168-25-000611
- form_type: 8-K
- ticker: SNOA
- cik: 0001367083
- company_name: Sonoma Pharmaceuticals, Inc.
- filed_at: 2025-01-30T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367083/000168316825000611/0001683168-25-000611-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367083/000168316825000611/sonoma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-000611
- JSON: https://secwatch.observer/filing/0001683168-25-000611.json
- Plain text: https://secwatch.observer/filing/0001683168-25-000611.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.